Abstract
Context and objectives
To examine the impact of a complementary/integrative medicine (CIM) program on quality of life (QoL)-related concerns among patients scheduled for chemotherapy for breast and gynecologic cancer.
Methods
Chemotherapy-naïve patients were referred by their oncology healthcare professional to an integrative oncology program, where CIM is provided as part of palliative/supportive care. CIM treatments were tailored to patients’ preferences and leading concerns, and for most included acupuncture and mind–body–spirit modalities, which were usually co-administered in the week preceding the first chemotherapy cycle. Patients attending the program were considered part of the treatment group; those who chose to receive only standard supportive care as controls. Assessment of quantitative outcomes was conducted during the week before chemotherapy; at 24 h before and after the treatment; and at 1 week post treatment. For this purpose, the Edmonton Symptom Assessment Scale (ESAS) and Measure Yourself Concerns and Well-being questionnaire (MYCAW) were used. Qualitative assessment was based on short narratives at the end of the follow-up MYCAW questionnaire, which were analyzed with ATLAS.Ti software for systematic coding.
Results
Of the 55 patients referred, 31 (56%) underwent CIM treatments, with 24 controls. Both groups had similar baseline demographic and cancer-related characteristics. QOL-related outcomes were significantly less impaired following CIM treatments for ESAS fatigue scores (P = 0.013), depression (P = 0.005), and feeling of well-being (P = 0.027); and MYCAW scores for well-being (P = 0.005) and emotional distress (P = 0.02). Qualitative analysis detected both specific and non-specific effects of the CIM treatment regimen, most describing a reduction in pre-chemotherapy anxiety.
Conclusion
A patient-tailored CIM program, initiated within a week of the first chemotherapy cycle, may help reduce the severity of fatigue, depression, and impaired well-being among patients with breast and gynecological cancers.
Similar content being viewed by others
References
Ben-Arye E, Schiff E, Shapira C, Frenkel M, Shalom T, Steiner M (2012) Modeling an integrative oncology program within a community-centered oncology service in Israel. Patient Educ Couns 89(3):423–429
Ben-Arye E, Samuels N, Schiff E, Raz OG, Sharabi IS, Lavie O (2015) Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy. Support Care Cancer 23(12):3411–3419
Bruera E, Kuehn N, Miller M, Selmser P, Macmillan K (1991) The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9
Chung KF, Yeung WF, Yu YM, Kwok CW, Zhang SP, Zhang ZJ (2015) Adverse events related to acupuncture: development and testing of a rating scale. Clin J Pain 31(10):922–928
Cutshall SM, Mahapatra S, Hynes RS, Van Rooy KM, Looker SA, Ghosh A, Schleck CD, Bauer BA, Wahner-Roedler DL (2017) Hand massage for cancer patients undergoing chemotherapy as outpatients: a pilot study. Explore (NY) 13(6):393–399
DiLorenzo TA, Jacobsen PB, Bovbjerg DH, Chang H, Hudis CA, Sklarin NT, Norton L (1995) Sources of anticipatory emotional distress in women receiving chemotherapy for breast cancer. Ann Oncol 6(7):705–711
Ivanauskienė R, Padaiga Ž, Šimoliūnienė R, Smailytė G, Domeikienė A (2014) Well-being of newly diagnosed women with breast cancer: which factors matter more. Support Care Cancer 22(2):519–526
Jacobsen PB, Bovbjerg DH, Redd WH (1993) Anticipatory anxiety in women receiving chemotherapy for breast cancer. Health Psychol 12(6):469–475
Kerner H, Samuels N, Ben Moshe S, Sharabi IS, Ben-Arye E (2017) Impact of a patient-tailored complementary/integrative medicine programme on disturbed sleep quality among patients undergoing chemotherapy. BMJ Support Palliat Care. https://doi.org/10.1136/bmjspcare-2017-001351
Keshet Y, Schiff E, Samuels N, Ben-Arye E (2015) Giving voice to cancer patients: assessing non-specific effects of an integrative oncology therapeutic program via short patient narratives. Psychooncology 24(2):169–174
Kim HJ1, Barsevick AM, Tulman L (2009) Predictors of the intensity of symptoms in a cluster in patients with breast cancer. J Nurs Scholarsh 41(2):158–165
Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, MacGillivray S (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32(14):1480–1501
Lin MF, Hsieh YJ, Hsu YY, Fetzer S, Hsu MC (2011) A randomised controlled trial of the effect of music therapy and verbal relaxation on chemotherapy-induced anxiety. J Clin Nurs 20(7–8):988–999
Molassiotis A, Yung HP, Yam BM, Chan FY, Mok TS (2002) The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial. Support Care Cancer 10(3):237–246
Montgomery GH, Tomoyasu N, Bovbjerg DH, Andrykowski MA, Currie VE, Jacobsen PB, Redd WH (1998) Patients’ pretreatment expectations of chemotherapy-related nausea are an independent predictor of anticipatory nausea. Ann Behav Med 20(2):104–109
Paterson C, Thomas K, Manasse A, Cooke H, Peace G (2007) Measure yourself concerns and wellbeing (MYCaW): an individualised questionnaire for evaluating outcome in cancer support care that includes complementary therapies. Complement Ther Med 15(1):38–45
Raghavendra RM, Nagarathna R, Nagendra HR, Gopinath KS, Srinath BS, Ravi BD, Patil S, Ramesh BS, Nalini R (2007) Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients. Eur J Cancer Care (Engl) 16(6):462–474
Rao MR, Raghuram N, Nagendra HR, Gopinath KS, Srinath BS, Diwakar RB, Patil S, Bilimagga SR, Rao N, Varambally S (2009) Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: a randomized controlled trial. Complement Ther Med 17(1):1–8
Shalom-Sharabi I, Samuels N, Lavie O, Lev E, Keinan-Boker L, Schiff E, Ben-Arye E (2017) Effect of a patient-tailored integrative medicine program on gastro-intestinal concerns and quality of life in patients with breast and gynecologic cancer. J Cancer Res Clin Oncol 143(7):1243–1254
Sjoquist KM, Friedlander ML, O’Connell RL, Voysey M, King MT, Stockler MR, Oza AM, Gillies K, Martyn JK, Butow PN (2013) Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study. Oncologist 18(11):1221–1228
Stephens PA, Osowski M, Fidale MS, Spagnoli C (2008) Identifying the educational needs and concerns of newly diagnosed patients with breast cancer after surgery. Clin J Oncol Nurs 12(2):253–258
Tas D, Uncu D, Sendur MA, Koca N, Zengin N (2014) Acupuncture as a complementary treatment for cancer patients receiving chemotherapy. Asian Pac J Cancer Prev 15(7):3139–3144
Todres L, Galvin KT, Holloway I (2009) The humanization of healthcare: a value framework for qualitative research. Int J Qual Stud Health Well-being 4:68–77
Acknowledgements
We would like to thank Ms. Ronit Leiba for her assistance in statistical analysis.
Funding
This study was not funded by any source.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Eran Ben-Arye declares that he has no conflict of interest. Hadeel Dahly declares that she has no conflict of interest. Yael Keshet declares that she has no conflict of interest. Jamal Dagash declares that he has no conflict of interest. Noah Samuels declares that he has no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
The research was conducted as part of the second author’s research project in the Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Rights and permissions
About this article
Cite this article
Ben-Arye, E., Dahly, H., Keshet, Y. et al. Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care. J Cancer Res Clin Oncol 144, 1825–1833 (2018). https://doi.org/10.1007/s00432-018-2700-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-018-2700-y